Loading clinical trials...

PROgastrine COlon DEpistage | Clinical Trials | Clareo Health

TERMINATEDNA

PROgastrine COlon DEpistage

Dosage of Progastrin in Asymptomatic Person Participating in Colon Cancer Screening

NCT03775473•ECS-Progastrin SA

View on ClinicalTrials.gov

Summary

Dosage of progastrin in asymptomatic person participating in colon cancer screening

Detailed Description

For anyone who will participate in colon screening at the Princess Grace Hospital of Monaco and who has signed the informed consent document. A blood test will be performed in addition to the screening test to assess the rate of progastrin.

Eligibility

Age

50 - 80 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•participant in colon cancer screening
•signing informed consent

Exclusion Criteria

•any major medical, psychiatric or addictive illness that would affect the informed consent process
•The consent of a representative is not allowed in this study

Locations (1)

Centre Hospitalier Princesse Grace, Monaco

Montpellier, MC, France

Key Dates

Start Date

February 7, 2019

Primary Completion Date

February 5, 2021

Completion Date

December 17, 2021

Last Updated

January 27, 2022

Enrollment

260

ACTUAL participants

Conditions

Colon Cancer ScreeningHealthy Person

Interventions

progastrin

DIAGNOSTIC_TEST

Colonoscopy Bowel Prep Comparison Among Diabetic Patients

NCT07351019

Colon Cancer Screening

View study

COMPLETED

The Relationship Between Upper Extremity Anthropometric Measurements and Reaction Time

NCT07357077

Healthy Persons

View study

COMPLETEDNA

Rural Colon Cancer Screening Toolkit Intervention

NCT04651504

Colon Cancer Screening

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions